This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 May 15;9(6):305.

doi: 10.1038/nrclinonc.2012.84.

Gynaecological cancer: OCEANS' three: the ovarian job

M Teresa Villanueva

PMID: 22585001
DOI: 10.1038/nrclinonc.2012.84

Comment

Gynaecological cancer: OCEANS' three: the ovarian job

M Teresa Villanueva. Nat Rev Clin Oncol. 2012.

. 2012 May 15;9(6):305.

doi: 10.1038/nrclinonc.2012.84.

Author

M Teresa Villanueva

PMID: 22585001
DOI: 10.1038/nrclinonc.2012.84

No abstract available

PubMed Disclaimer

Comment on

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR. Aghajanian C, et al. J Clin Oncol. 2012 Jun 10;30(17):2039-45. doi: 10.1200/JCO.2012.42.0505. Epub 2012 Apr 23. J Clin Oncol. 2012. PMID: 22529265 Free PMC article. Clinical Trial.

References

1. Nat Rev Clin Oncol. 2012 Feb 28;9(4):194-6 - PubMed
1. J Clin Oncol. 2012 Jun 10;30(17):2039-45 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.